FDA Authorizes Another Monoclonal Antibody 

February 16, 2022 by Alexa Hornbeck
FDA Authorizes Another Monoclonal Antibody 

The U.S. Food and Drug Administration recently issued an emergency use authorization for a new monoclonal antibody treatment called bebtelovimab from Eli Lilly, to help reduce the chances of severe illness in high-risk patients with COVID-19.

The Department of Health and Human Services issued a statement that the federal government would purchase 600,000 courses of the new monoclonal antibody treatment, even before the FDA issued the EUA based on data that shows it works against the omicron variant. 

HHS already agreed to receive 300,000 courses of the monoclonal antibody treatment in February, and will receive 300,000 courses in March. The contract also includes an option for 500,000 more doses. 

There are other monoclonal antibody treatments already on the market, such as Regeneron, also from Lilly, which did not show the same effectiveness against severe illness when it came to the omicron strain. The shipments of these two treatments were stopped on Dec. 23, 2021, by the federal government, but shipments resumed on Dec. 31, 2021.

Alexa can be reached at [email protected]

A+
a-

In The News

Health

Voting

Health

April 18, 2024
by Beth McCue
Salmonella Outbreak Linked to Fresh Basil 

ATLANTA — The Centers for Disease Control and Prevention on Thursday issued a food safety alert regarding Infinite Herbs organic... Read More

ATLANTA — The Centers for Disease Control and Prevention on Thursday issued a food safety alert regarding Infinite Herbs organic basil. As of the alert, 12 Salmonella cases in seven states have been reported. There are no reported deaths. The basil was sold at Trader Joe’s... Read More

April 17, 2024
by Dan McCue
Eli Lilly Obesity Drug Appears to Ease Sleep Apnea Symptoms in Trials

WASHINGTON — A pair of yearlong clinical trials conducted by the drug maker Eli Lilly appear to show that its... Read More

WASHINGTON — A pair of yearlong clinical trials conducted by the drug maker Eli Lilly appear to show that its obesity drug, Zepbound, can provide considerable relief to overweight people who have sleep apnea. Though the findings have yet to be published in a peer-reviewed medical... Read More

Idaho's Ban on Youth Gender-Affirming Care Has Families Desperately Scrambling for Solutions

Forced to hide her true self, Joe Horras’ transgender daughter struggled with depression and anxiety until three years ago, when... Read More

Forced to hide her true self, Joe Horras’ transgender daughter struggled with depression and anxiety until three years ago, when she began to take medication to block the onset of puberty. The gender-affirming treatment helped the now-16-year-old find happiness again, her father said. A decision by the... Read More

Weedkiller Manufacturer Seeks Lawmakers' Help to Squelch Claims It Failed to Warn About Cancer

DES MOINES, Iowa (AP) — Stung by paying billions of dollars for settlements and trials, chemical giant Bayer has been... Read More

DES MOINES, Iowa (AP) — Stung by paying billions of dollars for settlements and trials, chemical giant Bayer has been lobbying lawmakers in three states to pass bills providing it a legal shield from lawsuits that claim its popular weedkiller Roundup causes cancer. Nearly identical bills... Read More

April 16, 2024
by Dan McCue
Agency Sets Rules Limiting Miners’ Exposure to Hazardous Silica Dust

WASHINGTON — The Mine Safety and Health Administration issued a new rule on Tuesday aimed at better protecting the nation’s... Read More

WASHINGTON — The Mine Safety and Health Administration issued a new rule on Tuesday aimed at better protecting the nation’s miners from health hazards associated with exposure to respirable crystalline silica, also known as silica dust.  Inhaling crystalline silica, a known carcinogen, can cause serious lung... Read More

Biden Administration Announces Partnership With 50 Countries to Stifle Future Pandemics

WASHINGTON (AP) — President Joe Biden's administration will help 50 countries identify and respond to infectious diseases, with the goal... Read More

WASHINGTON (AP) — President Joe Biden's administration will help 50 countries identify and respond to infectious diseases, with the goal of preventing pandemics like the COVID-19 outbreak that suddenly halted normal life around the globe in 2020. U.S. government officials will work with the countries to develop better testing, surveillance,... Read More

News From The Well
scroll top